Trial intelligence / Profile preview

FatCovid-19: Chronic Fatigue in Covid-19 ICU Survivors

NCT04363606Terminated

Sponsor
CHU Saint-Etienne
Start
May 2020
Primary completion
Aug 2021
Countries
1
01

Overview

Open-label trial (3 arms), sponsored by CHU Saint-Etienne. Primary endpoint: voluntary maximum force reduction. Started May 2020; status: terminated.

Beyond the preview

Go deeper on NCT04363606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04363606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call